Boston Scientific: Oppenheimer cuts to perform from outperform
BSX•Oppenheimer cut its rating on Boston Scientific to perform from outperform.
Related News
Madison Square Garden Entertainment to host fiscal 2027 first-quarter results call
MSGE•
Eclypsium working with Nvidia to advance infrastructure assurance
NVDA•
Wall Street set for lower open as Alphabet results reignite AI spending fears
SPY•
Perrigo announces agreement to divest infant formula business to Meridianmade
PRGO•
Cadence joins DOE's Genesis Mission Consortium to advance AI-driven research
CDNS•